TNFA: TNF Pharmaceuticals, Inc. Narxning prognoz qilingan daromadga nisbati

TNF Pharmaceuticals (TNFA) korporativ emblemasi va logotipi

GURU.Markets platformasida TNF Pharmaceuticals (TNFA) uchun kutilayotgan P/S grafigi baholash dinamikasini aks ettiradi, bunda ushbu ko'rsatkich darajasiga yetgan. Kotirovkalar bozor sikllarini chetlab o'tib, qarishga qarshi dori vositalarini ishlab chiqish muvaffaqiyati bilan boshqarilmoqda. Biroq, Osiyodan xomashyo yetkazib berishning buzilishi kabi tashqi risklar o'sishni sekinlashtirishi mumkin. Shu bilan birga, rahbariyat yallig'lanishga qarshi kurashish uchun noyob molekulalarning sinovlarini samarali muvofiqlashtirmoqda.

TNF Pharma - TNFA Kelajakdagi narxning daromadga nisbati (davr: 04.07.2022 - 14.11.2026)

tnfpharma.com (TNFA) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va konsensus maqsadli narx:
Aksiya kotirovkalari TNF Pharmaceuticals, Inc.|TNFA - Tahlilchilarning prognoz narxlari
- bozor kapitallashuvi haqida ma'lumot:
Bozor qiymati TNF Pharmaceuticals, Inc.|TNFA - Biznes qiymati
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati TNF Pharmaceuticals|TNFA - Sof aktivlar qiymati|Kapitallashuvning sof aktivlarga nisbati tnfpharma.com|TNFA - Aktivlarning umumiy qiymati
- kompaniyaning jami qarzi va likvidligi ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati TNF Pharmaceuticals|TNFA - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati TNF Pharmaceuticals, Inc.|TNFA - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar TNF Pharmaceuticals, Inc.|TNFA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi TNF Pharmaceuticals|Tezkor likvidlik tnfpharma.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
TNFA - Sof daromad|Prognoz qilingan kelajakdagi foyda TNF Pharmaceuticals|TNFA - P/E multiplikatori|Forvard P/E multiplikatori TNF Pharmaceuticals, Inc.|TNFA - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori TNF Pharmaceuticals, Inc.|TNFA - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda TNF Pharmaceuticals|TNFA - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi tnfpharma.com|TNFA - Joriy yil uchun bitta aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi TNF Pharmaceuticals
- sotuv hajmi va tushum haqida ma'lumot:
TNFA - Kompaniyaning yalpi daromadi|Prognoz qilingan sotish hajmi TNF Pharmaceuticals, Inc.|TNFA - Kapitalizatsiyaning daromadga nisbati|Forvard P/S multiplikatori TNF Pharmaceuticals, Inc.
Kompaniyaning jamlanma tahlili:TNF Pharma TNFA
tnfpharma.com original mahsuloti

Hissiy aktivning ishonchliligi bozor qiymatini kutilayotgan pul oqimlari bilan solishtirish orqali aniqlanadi. Kelgusidagi sotuvlar nisbatidagi narx koeffitsiyenti kelajakdagi sotuvlarning bir birligi uchun biznes qiymatini o'lchaydi, bu esa TNF Pharmaceuticals (TNFA) kompaniyasining tadqiqot va ishlanmalarga (R&D) yo'naltirilgan boshqaruvi tufayli, aktivning sanoat kontekstiga nisbatan haddan tashqari sotib olingani yoki qadrsizlanganini aniqlash uchun kompaniyaning forward P/S baholashidan foydalangan holda innovatsion investitsiyalar samaradorligini baholash imkonini beradi.

TNF Pharmaceuticals raqobatchilari

Haleon - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati KVUE (Kenvue Inc)|VRNA - Narxning prognoz qilingan daromadga nisbati|MENS (Jyong Bio) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|LGND: Forvard P/S multiplikatori|Kelajakdagi narxning daromadga nisbati AMRX (amneal.com)|Forvard narx/daromad multiplikatori PRGO|ALVO: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Liquidia Technologies (LQDA)|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals)|Sotuvga nisbatan forvard narx MNKD|Amphastar Pharmaceuticals, Inc. - Forvard P/S multiplikatori|PCRX - Forvard P/S multiplikatori|ARS Pharma (SPRY) - Narxning prognoz qilingan daromadga nisbati|Theravance Corp - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Aquestive Therapeutics|Forvard narx/daromad multiplikatori scPharma (SCPH)|Forvard P/S multiplikatori TECX|Forvard P/S multiplikatori Tonix Pharma (TNXP)|Forvard P/S multiplikatori SXTC (China SXT Pharmaceuticals, Inc.)|EPRX - Forvard narx/daromad multiplikatori|BioHarvest Sciences - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati invizyne.com|ORMP (oramed.com) - Forvard narx/daromad multiplikatori|Entera Bio (ENTX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori HYFT|ABVC (ABVC BioPharma, Inc) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori CPIX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati quantumbiopharma.com|Forvard P/S multiplikatori FGEN (FibroGen)|TELO - Forvard narx/daromad multiplikatori|Rani Therapeutics Inc - Forvard P/S multiplikatori|SNYR - Forvard P/S multiplikatori|rallybio.com (RLYB) - Narxning prognoz qilingan daromadga nisbati|LEXX (Lexaria Bioscience Corp.) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Pulmatrix|Pheton (PTHL) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori APM (Aptorum Group Limited)|Narxning kutilayotgan daromadga nisbati LYRA|Narxning prognoz qilingan daromadga nisbati Impact BioMedical Inc IBO|YCBD: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|PainReform - Forvard P/S multiplikatori|Kelajakdagi narxning daromadga nisbati CYTO|LIPO: Forvard P/S multiplikatori|OptiNose Corp (OPTN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals|procapsgroup.com - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori PTPI|QLI (Qilian International Holding Group) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SLRN (ACELYRIN, Inc.)|Forvard P/S multiplikatori TFF Pharmaceuticals, Inc TFFP